No consistent changes were observed for the expression of EMT-related molecules in cancer cells treated with GSK3β inhibitor, in contrast to a previous study that found GSK3β inhibits EMT by phosphorylating and destabilizing snail, a transcriptional repressor of E-cadherin [30]. This evidence concerns the gene SNAI1 and cancer.